Yi Ying | White & Case LLP International Law Firm, Global Law Practice
Yi Ying
Yi Ying

Yi Ying

Associate, Washington, DC, Shanghai

T +1 202 729 2425

T +86 21 6132 5900

E [email protected]


Mr. Ying is a member in White & Case's Global Competition Practice Group. His practice focuses on antitrust investigations and litigation, merger clearance and other commercial litigation matters. Mr. Ying represents clients in investigations by various antitrust agencies, including experience before the Department of Justice, the Federal Trade Commission and state agencies. He is also involved in cases in both federal and state courts.

Mr. Ying has experience with Chinese antitrust issues. He is also serving as a special writer for a Chinese national newspaper on the topic of Chinese antitrust and security enforcement developments.

In addition to his legal education in the US, Mr. Ying obtained his civil law degree from a top Japanese college. Mr. Ying was a summer associate in our Tokyo office during his first summer at law school, and he spent the second summer with our Washington office. Mr. Ying is also a native speaker of Mandarin and Shanghainese. Prior to joining the Firm, Mr. Ying worked at a Magic Circle law firm's Shanghai office as a Chinese Legal Consultant for two years. Mr. Ying is also committed to serving pro bono clients on behalf of the Firm, and he has been involved in various matters.

Bars and Courts

  • Chinese National Bar
  • District of Columbia Bar
  • Illinois State Bar
  • New York State Bar


  • JD, Ohio State University College of Law
  • LLB, Waseda University, Tokyo, Japan
  • Political Science, University of California, Los Angeles


  • English
  • Japanese
  • Mandarin
  • Shanghainese


Advising a national pharmaceutical company regarding a subpoena filed by the New York Attorney General.

Representing a top US home construction company in civil antitrust litigation.

Represented an executive of a leading Japanese auto parts manufacturer in a DOJ cartel investigation.

Defended a multinational airline company in an investigation of alleged market allocation and price fixing.

Advised Hepalink, one of the largest Chinese pharmaceutical companies, in its US$337.5 million acquisition of Scientific Protein Laboratories, LLC, a leading US active pharmaceutical ingredients (APIs) manufacturer.

Speaking Engagements

"Introduction to US Antitrust Law", 11 September 2014: The Shanghai Bar Association, Shanghai, China, Presenter (in Madarin)


  • Blocked Shipping Alliance Reveals Modest Improvement in Chinese Antitrust Review transparency, Washington Legal Foundation Legal Backgrounder, August 22, 2014, With Noah Brumfield
  • A look at 1st M&A Deals Under China's New Review Process, Law360, August 8, 2014, With Noah Brumfield, Alex Zhang and Lucy Xu